![](https://www.fda.gov/themes/custom/preview/img/FDA-Social-Graphic.png)
Cholrem Pty Ltd dba Cholrem and Cholrem Pharmaceuticals - 684036 - 07/09/2024
Delivery Method: Via Email Product: Drugs WARNING LETTER July 9, 2024 RE: 684036 Dear Kyle Hodgetts: This letter is to advise you that the United States (U.S.) Food and Drug Administration (FDA) reviewed your websites at www.cavadex.com, www.cholrem.com, …